Vertex Pharmaceuticals (NASDAQ: VRTX)
Vertex Pharmaceuticals Return vs. S&P
1 Year | 5 Year | 5 Year Annualized | Since IPO |
---|
Vertex Pharmaceuticals Company Info
Vertex is in the business of discovering, developing, and commercializing small-molecule drugs for the treatment of serious genetic diseases including cystic fibrosis.
News & Analysis
Got $500? 3 Pharma Stocks to Buy and Hold Forever
These players might even beat the market when the conditions are right.
Is It Too Late to Buy Vertex Pharmaceuticals Stock?
Shares of the growing biotech company have doubled in three years.
2 Biotech Stocks to Buy in May
You could buy these in any month, really.
These Are Billionaires’ Favorite Healthcare Stocks
The Motley Fool analyzed 16 billionaire-led hedge funds to get an idea of their healthcare sector investment strategies.
Vertex Pharmaceuticals Is Racing Towards a New Blockbuster: Why the Stock Is a Smart Buy
The biotech's shares dropped following its latest quarterly update, but that shouldn't matter to long-term investors.
2 Unbelievable Growth Stocks You Can Buy and Hold for the Next Decade
These companies are raking in profits at astonishing clips.
5 Reasons Vertex Pharmaceuticals Is a Screaming Buy on the Dip
New drugs in development and a lack of significant patent cliffs ahead make this a great pharma stock to buy now and hold over the long run.
3 No-Brainer Stocks to Buy in May
These great stocks are great picks for investors as spring winds down.
Valuation
Podcast Episodes
Alleged Industrial Espionage Makes an Interesting Story
We also chat about Vertex Pharmaceuticals and its role at the center of cystic fibrosis treatment.
3 Biotech Companies Analyzed
We examine three biotech companies' past performances and future outlooks.
Is Amarin's Fish Oil Pill on Track to Become a Blockbuster?
Plus, how gene-editing company CRISPR Therapeutics just took a big step forward.
Earnings Transcripts
Vertex Pharmaceuticals (VRTX) Q1 2024 Earnings Call Transcript
VRTX earnings call for the period ending March 31, 2024.
Vertex Pharmaceuticals (VRTX) Q4 2023 Earnings Call Transcript
VRTX earnings call for the period ending December 31, 2023.
Vertex Pharmaceuticals (VRTX) Q3 2023 Earnings Call Transcript
VRTX earnings call for the period ending September 30, 2023.
Vertex Pharmaceuticals (VRTX) Q2 2023 Earnings Call Transcript
VRTX earnings call for the period ending June 30, 2023.
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.